Related Experiment Videos
Isolation and phenotypic characterization of CD117-positive cells
1Children's Hospital, University of Tübingen, Germany.
Leukemia Research
|November 1, 1996
Summary
This study presents a magnetic cell separation method to enrich CD117-expressing stem cells from cord blood. The technique yields highly pure hematopoietic progenitors, offering a new approach for stem cell transplantation.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Cord blood is a rich source of hematopoietic stem cells.
- Efficient isolation of specific cell populations is crucial for therapeutic applications.
- CD117 is a well-established marker for hematopoietic stem and progenitor cells.
Purpose of the Study:
- To develop and validate a magnetic cell separation (MACS) technique for enriching CD117-expressing mononuclear cells from cord blood.
- To assess the purity and characteristics of the isolated cell population.
- To evaluate the potential of this method for stem cell enrichment in autologous transplantation.
Main Methods:
- Mononuclear cells from cord blood were stained with a CD117-specific antibody conjugated to fluorochrome.
- Cells were further labeled with supermagnetic microparticle-conjugated antibodies.
- Magnetic cell separation (MACS) was employed for cell enrichment.
- Flow cytometry was used to analyze cell phenotype, size, and expression of CD117 and CD34.
Main Results:
- The MACS technique successfully enriched CD117-expressing cells to 96.5% purity.
- Flow cytometry revealed two distinct cell populations based on size.
- A majority of large cells (93%) exhibited a CD117 and CD34 positive phenotype.
- The isolated cell population contained a significant fraction (16%) of hematopoietic progenitors.
Conclusions:
- The described MACS technique provides an effective alternative for stem cell enrichment.
- The high purity of CD117+ and CD34+ cells suggests their potential as hematopoietic progenitors.
- This method may be valuable for autologous transplantation procedures requiring enriched hematopoietic stem cells.